ArticleHeart (British Cardiac Society)1999

Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.

D M Pickin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.